1 year return (CAGR)
-85.25%
Greenlight Biosciences Holdings PBC Exchange (NASDAQ, USD)
GRNA
-
0.00 (0.00%)
HealthcareBiotechnology & Medical Research
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
45.43M
Price/Sales
4.45
Ent value
104.83M
Price/Book
2.07
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.30 |
| Daily high | 0.30 |
| Daily low | 0.30 |
| Daily Volume | 0K |
| 1y analyst estimate | 0.60 |
| Beta | 1.44 |
| EPS (TTM) | -1.04 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GRNA | S&P500 | |
| Current price drop from All-time high | -97.79% | -5.28% |
| Highest price drop | -98.69% | -56.47% |
| Date of highest drop | 24 May 2023 | 9 Mar 2009 |
| Avg drop from high | -75.51% | -10.68% |
| Avg time to new high | 42 days | 12 days |
| Max time to new high | 340 days | 1805 days |
News
No items found